Waters CorporationWATEarnings & Financial Report
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries.
WAT Q3 2025 Key Financial Metrics
营收
$799.9M
毛利润
N/A
营业利润
$192.1M
净利润
$148.9M
毛利率
N/A
营业利润率
24.0%
净利率
18.6%
同比增长
8.0%
EPS
$2.50
资金流向
Waters Corporation Q3 2025 Financial Summary
Waters Corporation reported revenue of $799.9M for Q3 2025, with a net profit of $148.9M (18.6% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $799.9M |
|---|---|
| Net Profit | $148.9M |
| Gross Margin | N/A |
| Operating Margin | 24.0% |
| Report Period | Q3 2025 |
Waters Corporation Annual Revenue by Year
Waters Corporation annual revenue history includes year-by-year totals (for example, 2024 revenue was $3.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $3.0B |
| 2023 | $2.9B |
| 2022 | $2.8B |
利润表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $819.5M | $636.8M | $708.5M | $740.3M | $872.7M | $661.7M | $771.3M | $799.9M |
| 同比增长 | 15.7% | -7.0% | 3.5% | -0.0% | 6.5% | 3.9% | 8.9% | 8.0% |
资产负债表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $4.63B | $4.51B | $4.45B | $4.51B | $4.55B | $4.59B | $4.72B | $4.86B |
| 总负债 | $3.48B | $3.25B | $3.04B | $2.91B | $2.73B | $2.63B | $2.56B | $2.53B |
| 股东权益 | $1.15B | $1.26B | $1.41B | $1.60B | $1.83B | $1.96B | $2.16B | $2.33B |
现金流量表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $230.1M | $262.9M | $54.5M | $204.6M | $240.1M | $259.6M | $41.1M | $187.3M |
Other Health Care Companies
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M
AMGN
Amgen
营收
$9.9B
净利润
$1.3B
BAX
Baxter International
营收
$3.0B
净利润
$-1.1B
BDX
Becton Dickinson
营收
$5.3B
净利润
$382.0M
TECH
Bio-Techne
营收
$295.9M
净利润
$38.0M
BIIB
Biogen
营收
$2.3B
净利润
$-48.9M
BSX
Boston Scientific
营收
$5.3B
净利润
$670.0M